Caplin Point Laboratories Limited (CAPLIPOINT) Stock Statistics & Valuation Metrics

Caplin Point Laboratories Limited has a market cap or net worth of ₹145.28B. The enterprise value is ₹137.06B.

Caplin Point Laboratories Limited has 76,011,696 shares outstanding. The number of shares has decreased by -2.65% in one year.

Caplin Point Laboratories Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Caplin Point Laboratories Limited is ―. Caplin Point Laboratories Limited’s PEG ratio is ―.

In the last 12 months, Caplin Point Laboratories Limited had revenue of 16.77B and earned 4.57B in profits. Earnings per share was 59.90.

In the last 12 months, operating cash flow was 513.20M and capital expenditures 0.00, giving a free cash flow of 513.20M billion.

Caplin Point Laboratories Limited pays an annual dividend of ₹5, resulting in a dividend yield of 0.25%

Caplin Point Laboratories Limited upcoming earnings date is May 23, 2025, TBA Not Confirmed.

Caplin Point Laboratories Limited as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Caplin Point Laboratories Limited has paid 1.03B in taxes.

Caplin Point Laboratories Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Caplin Point Laboratories Limited has ₹7.91B in cash and marketable securities with ₹5.41M in debt, giving a net cash position of -₹7.91B billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Caplin Point Laboratories Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―